Publicaciones en las que colabora con Marcos González Díaz (3)

2021

  1. Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)

    PLoS ONE, Vol. 16, Núm. 9 September

2018

  1. Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology

    British Journal of Haematology

1998

  1. Preliminary experience in external quality control of RT-PCR PML-RARα detection in promyelocytic leukemia

    Leukemia, Vol. 12, Núm. 12, pp. 2024-2028